Table 1. Number of identified guidelines, number of reviewers, year of guideline publication, 90–90–90 goals and late HIV diagnosis per participating European country, 2019–2021 (n = 15).
Country | Number of identified guidelines | Number of reviewers | Year of guideline publication, median (IQR) |
Estimated total people living with HIVa | People diagnosed with HIVa | People diagnosed with HIV on ARTa | People on ART who are virally suppresseda | Number of cases with CD4+ T-cell countb | People with late HIV diagnosis in 2020c
(CD4+ T-cells < 350 cells /µL)d |
|||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | n | % | n | % | |||||
Western Europe | ||||||||||||||
Belgium | 31 | 1 | 2013 (2012–2017) |
18,335 | 16,594 | 91 | 15,238 | 92 | 14,299 | 94 | 500 | 70 | 203 | 41 |
Denmark | 83 | 4 | 2019 (2018–2020) |
6,750 | 6,150 | 91 | 5,670 | 92 | 5,550 | 98 | 96 | 89 | 58 | 61 |
France | 65 | 2 | 2013 (2009–2016) |
172,700 | 148,746 | 86 | 133,400 | 90 | 126,800 | 95 | 1,972 | 58 | 1,025 | 52 |
Germany | 61 | 7 | 2018 (2014–2019) |
87,900 | 77,300 | 88 | 71,400 | 92 | 68,000 | 88 | 732 | 30 | 383 | 52 |
Greece | 41 | 2 | 2015 (2015–2016) |
15,980 | 13,345 | 84 | 10,618 | 80 | NA | NA | 423 | 71 | 241 | 51 |
Italy | 38 | 5 | 2015 (2012–2018) |
130,000 | 124,500 | 96 | 117,000 | 94 | 102,000 | 87 | 1,223 | 94 | 734 | 60 |
The Netherlands | 71 | 3 | 2017 (2014–2018) |
23,300 | 21,360 | 92 | 19,913 | 93 | 19,046 | 96 | 371 | 94 | 190 | 51 |
Switzerland | 34 | 1 | 2018 (2016–2019) |
16,700 | 15,500 | 93 | 15,000 | 97 | 14,800 | 99 | 168 | 59 | 88 | 52 |
United Kingdom | 79 | 3 | 2011 (2009–2013) |
103,800 | 96,142 | 93 | 93,384 | 97 | 90,583 | 97 | 2,408 | 87 | 1,005 | 42 |
Eastern Europe | ||||||||||||||
Belarus | 47 | 1 | 2018 (2012–2018) |
26,000 | 22,084 | 85 | 11,714 | 80 | 13,575 | 77 | 1,105 | 78 | 398 | 36 |
Poland | 37 | 3 | 2016 (2013–2018) |
15,166 | 12,385 | 82 | 10,496 | 85 | 10,052 | 96 | NA | NA | NA | NA |
Lithuania | 52 | 2 | 2015 (2014–2017) |
3,397 | 2,827 | 77 | 1,223 | 43 | 920 | 75 | NA | NA | NA | NA |
Romania | 29 | 4 | 2014 (2010–2015) |
18,000 | 16,486 | 92 | 12,644 | 77 | 8,064 | 64 | 407 | 93 | 228 | 56 |
Russia | 44 | 1 | 2016 (2014–2017) |
998,525 | 808,823 | 81 | 319,613 | 40 | 271,671 | 85 | 57,071 | 96 | 16,150 | 27 |
Ukraine | 76 | 3 | 2016 (2007–2016) |
251,168 | 169,787 | 58 | 136,105 | 80 | 127,871 | 94 | 13,791 | 89 | 7,513 | 55 |
ART: antiretroviral therapy; IQR: interquartile range; NA: not available.
a Data from Continuum of HIV Care, monitoring implementation Dublin 2020 [2].
b New HIV diagnoses in 2020 among persons > 14 years with CD4+ T-cell count levels reported.
c Completeness of number of cases with CD4+.
d Data from HIV/AIDS surveillance in Europe 2020 [5].
Participating countries were European countries involved in the established infrastructure of the Optimising Testing and Linkage to Care for HIV across Europe (OptTEST) project.